Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
GERN > SEC Filings for GERN > Form 8-K on 19-Dec-2008All Recent SEC Filings

Show all filings for GERON CORP | Request a Trial to NEW EDGAR Online Pro

Form 8-K for GERON CORP


19-Dec-2008

Change in Directors or Principal Officers


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Compensatory Arrangements of Certain Officers

     On December 16, 2008, the Compensation Committee of the Board of Directors
of Geron Corporation (the "Company") approved (a) annual base salaries for 2009,
which are the same as the 2008 annual base salaries and (b) cash performance
bonuses for 2008 for the following principal executive officer, principal
financial officer and named executive officers of the Company:

--------------------------------------------------------------------------------------------------
                                                        2009
                                                       Salary            2009            2008
Name and Position                                     Increase        Base Salary     Cash Bonus
--------------------------------------------------------------------------------------------------

--------------------------------------------------------------------------------------------------
Thomas B. Okarma, Ph.D., M.D.                        $    --         $   535,000    $    280,900
   President and CEO
--------------------------------------------------------------------------------------------------
David L. Greenwood                                   $    --         $   415,000    $    163,400
   Executive Vice President and CFO
--------------------------------------------------------------------------------------------------
Fabio M. Benedetti, M.D.                             $    --         $   350,000    $    102,300
   Senior Vice President, Chief Medical
   Officer, Oncology
--------------------------------------------------------------------------------------------------
David J. Earp, J.D., Ph.D.                           $    --         $   325,000    $    113,800
   Senior Vice President, Bus. Dev. and
   Chief Patent Counsel
--------------------------------------------------------------------------------------------------
Calvin B. Harley, Ph.D.                              $    --         $   315,000    $     96,500
   Chief Scientific Officer
--------------------------------------------------------------------------------------------------
Melissa Kelly Behrs                                  $    --         $   320,000    $    112,000
   Senior Vice President, Therapeutic
   Development, Oncology
--------------------------------------------------------------------------------------------------
Jane S. Lebkowski, Ph.D.                             $    --         $   335,000    $    117,300
   Senior Vice President, Regenerative
   Medicine
--------------------------------------------------------------------------------------------------

  Add GERN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for GERN - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.